Riskpilot← Back to searchSign inGet full accessOMDA PREDICARE AS
ASActiveOrg 917350019Drammensveien 288, 0283 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 20161 employees
Revenue 2024
NOK 3,4M
+5% vs 2023
EBITDA margin
5.2%
+19% vs 2023
Equity ratio
59.6%
Financial strength
Net profit 2024
NOK 139K
+20% vs 2023
| Revenue | NOK 3,4M | +5% |
| EBITDA | NOK 174K | +19% |
| Net profit | NOK 139K | +20% |
| Total assets | NOK 641K | -12% |
| Equity | NOK 382K | +0% |
| Employees | 1 | — |
Legal name
OMDA PREDICARE AS
Org number
917350019
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
28. juni 2016
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Bedriften arbeider innenfor helsesektoren, med fokus på medisinske produkter. Virksomhetens fokus er å hjelpe helsepersonell ved å gjøre riktige akuttmedisinske beslutninger og relatert virksomhet.
Address
Drammensveien 288, 0283 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 80 | 1 004 | 1 189 | 1 309 | 1 563 | 1 659 | 2 996 | 3 197 | 3 371 |
| Staff expenses | −0 | −76 | −181 | −251 | −315 | −388 | −413 | −452 | −487 |
| EBITDA | 25 | 42 | 55 | 48 | 41 | 37 | 150 | 146 | 174 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 25 | 42 | 55 | 48 | 41 | 37 | 150 | 146 | 174 |
| Net financials | 0 | −7 | −14 | −9 | −55 | 2 | −10 | 3 | 4 |
| Profit before tax | 25 | 35 | 41 | 39 | −14 | 39 | 139 | 149 | 178 |
| Tax | −0 | 8 | 12 | 6 | −0 | 6 | 31 | 33 | 39 |
| Net profit | 25 | 27 | 29 | 33 | −14 | 34 | 109 | 116 | 139 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 110 | 120 | 160 | 201 | 182 | 230 | 1 183 | 730 | 641 |
| Equity | 55 | 76 | 105 | 138 | 124 | 158 | 266 | 382 | 382 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 55 | 44 | 55 | 64 | 58 | 72 | 917 | 348 | 259 |
| Total debt | 55 | 44 | 55 | 64 | 58 | 72 | 917 | 348 | 259 |
EBITDA margin
5.2%
This company
15.8%
Market median
-67% vs market
20162024
Equity ratio
59.6%
This company
38.2%
Market median
+56% vs market
20162024
Return on equity
36.3%
This company
18.4%
Market median
+97% vs market
20162024
Net profit margin
4.1%
This company
8.1%
Market median
-49% vs market
20162024
Asset turnover
5.26×
This company
1.12×
Market median
+370% vs market
20162024
Debt / equity
0.68×
This company
0.62×
Market median
+10% vs market
20162024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SM Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
AB Deputy Member | Deputy Member | 2020 | — | — |
DJ Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Chairman | 2025 | — | — | |
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Predicare Ab | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OMDA PREDICARE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sven Mathias Myren | Chief Executive Officer | 0 companies |
| Artur Bernardino Aira | Deputy Member | 0 companies |
| Daniel Johan Pote | Chief Executive Officer | 0 companies |
| Sverre Flatby | Board of Directors | 0 companies |
| Einar Tørris Bonnevie | Chairman | 0 companies |
| Bengt Roland Widgren | Chairman | 0 companies |